Premium
Review of Chinese young adults' human papillomavirus knowledge, attitudes, and vaccine acceptability
Author(s) -
Ou Lihong,
Chen Angela ChiaChen,
Reifsnider Elizabeth
Publication year - 2021
Publication title -
public health nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 55
eISSN - 1525-1446
pISSN - 0737-1209
DOI - 10.1111/phn.12893
Subject(s) - medicine , cinahl , young adult , psycinfo , vaccination , human papillomavirus , hpv vaccines , psychological intervention , medline , mainland china , family medicine , hpv infection , china , cervical cancer , gerontology , immunology , cancer , nursing , political science , law
Objective The human papillomavirus (HPV) vaccine is effective in reducing HPV‐related disease. The 2‐, 4‐, and 9‐valent HPV vaccines have been approved by the Chinese FDA since 2016; however, factors associated with HPV vaccine acceptability and use in Chinese young adults remain unclear. Design and Sample We conducted a systematic review to analyze factors affecting HPV vaccine acceptability and use in Chinese young adults. A comprehensive search of databases (e.g., PubMed, CINAHL, and PsycINFO) was conducted, and articles between 2011 and 2020 were included. Results Seventeen studies were included in the final review, and eleven were conducted in mainland China and six in Hong Kong. All studies reported low level of HPV‐related knowledge. Better knowledge, more concerns about HPV‐associated diseases, and being female were found associated with higher vaccine acceptability. The vaccine cost and safety were the major concerns for vaccination. Conclusions Findings suggested a low level of HPV‐related knowledge and suboptimal vaccination rate in Chinese young adults. Theory‐based interventions addressing knowledge and other influencing factors and involving both males and females are urgently needed to increase vaccine acceptability and use in Chinese young adults.